These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22233302)

  • 21. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
    Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
    Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of respiratory symptoms in severe COPD.
    Espinosa de los Monteros MJ; Peña C; Soto Hurtado EJ; Jareño J; Miravitlles M
    Arch Bronconeumol; 2012 Jan; 48(1):3-7. PubMed ID: 21944843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD patients treated with or without inhaled steroids.
    Paone G; Lanata L; Saibene F; Toti S; Palermo P; Graziani C; Flore MC; Ramaccia M; Puglisi G
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6727-6735. PubMed ID: 31378916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptom variability over the course of the day in patients with stable COPD in Brazil: a real-world observational study.
    Cukier A; Godoy I; Costa CHD; Rubin AS; Gregorio MG; Albuquerque Neto AA; Lima MA; Pereira MC; Tanni SE; Athanazio RA; Bessa EJC; Wehrmeister FC; Lourenco CB; Menezes AMB
    J Bras Pneumol; 2020; 46(3):e20190223. PubMed ID: 31859705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey.
    Partridge MR; Karlsson N; Small IR
    Curr Med Res Opin; 2009 Aug; 25(8):2043-8. PubMed ID: 19569976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010?
    Decramer M; Brusselle G; Buffels J; Corhay JL; De Backer W; Degryse JM; Janssens W; Marchand E; Van den Brande P; Vincken W; Gayan-Ramirez G; Van Craenendonck V; Vandenberghe H; De Vuyst P;
    Acta Clin Belg; 2013; 68(5):325-40. PubMed ID: 24579239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute exacerbations of chronic obstructive pulmonary disease].
    Chabot F; Gomez E; Guillaumot A; Kheir A; Chaouat A
    Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
    Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
    Zuwallack RL; Nici L
    COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).
    Celli B; Halpin D; Hepburn R; Byrne N; Keating ET; Goldman M
    Respir Med; 2003 Jan; 97 Suppl A():S35-43. PubMed ID: 12564609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real world COPD: association of morning symptoms with clinical and patient reported outcomes.
    Roche N; Small M; Broomfield S; Higgins V; Pollard R
    COPD; 2013 Dec; 10(6):679-86. PubMed ID: 24127914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease severity and symptoms among patients receiving monotherapy for COPD.
    Dransfield MT; Bailey W; Crater G; Emmett A; O'Dell DM; Yawn B
    Prim Care Respir J; 2011 Mar; 20(1):46-53. PubMed ID: 20886200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of night-time symptoms in COPD: a real-world study in five European countries.
    Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.